Featuring an interview with Ms Charise Gleason, including the following topics:
- Progress and change in the management of multiple myeloma (MM) (0:00)
- Patient- and disease-specific factors guiding therapeutic decision-making for newly diagnosed MM (5:11)
- Role of anti-CD38 antibodies in the management of MM (12:14)
- Emerging treatment options for smoldering myeloma (23:08)
- Optimizing long-term outcomes for patients with MM (25:38)
- Tailoring therapy for older adults and patients with preexisting comorbidities (29:59)
- Case: A woman in her early 80s with newly diagnosed transplant-ineligible MM who experienced a complete response with first-line daratumumab/lenalidomide and low-dose dexamethasone (34:34)
- Case: A man in his early 60s with progressive back pain from standard-risk MM who experienced a complete response with daratumumab with lenalidomide/bortezomib/dexamethasone (42:05)
- Building therapeutic relationships and integrating holistic care in oncology practice (47:13)
Fler avsnitt av Research To Practice | Oncology Videos
Visa alla avsnitt av Research To Practice | Oncology VideosResearch To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
